Mark Reding
Professor of Medicine, Division of Hematology, Oncology and Transplantation · University of Minnesota
Credentials: · ·
History
- Present
- 1995–1998
Hematology and Medical Oncology
- 1992–1995
Internal Medicine
Research
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
New England Journal of Medicine · 2023 · 178 citations
Journal of Thrombosis and Haemostasis · 2013 · 158 citations
Journal of Thrombosis and Haemostasis · 2014 · 123 citations
8 papers
7 papers
6 papers
5 papers
4 papers
- LM
4 papers
4 papers
4 papers
Grants
- 2005–2009
GCRC-General Clinical Research Center
National Center for Research Resources · M01
Project lead · $19.6K · University of Minnesota
Clinical trials
- 2021–2027
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Principal investigator · Recruiting · Phase 4
American Thrombosis and Hemostasis Network